Answers are grounded in this paper and cite their sources.
Case report demonstrates improvement in pulmonary hypertension after stem cell transplant for multiple myeloma, suggesting potential therapeutic avenues.
Introduction Pulmonary hypertension (PH) is a heterogenous disease with many etiologies. Diagnosis of PH is typically suspected in transthoracic echocardiography (TTE) and confirmed by right heart catheterization (RHC). Multiple myeloma (MM) is a plasma cell dyscrasia due to clonal proliferation of plasma cells, which is rarely associated with PH. The pathophysiology of MM-related PH is unclear and likely multifactorial including cardiac amyloidosis, high output heart failure, drug toxicity and volume overload. Clinical outcomes are worse for patients with this condition. We report a case of MM with PH where PH significantly improved after stem cell transplant. Case Description A 53-year-old female with MM presented to clinic with shortness of breath. On initial TTE, she had pulmonary artery systolic pressure of 91 mmHg. Cardiac MRI confirmed dilation of the right heart chambers with tricuspid valve regurgitation. RHC confirmed pulmonary artery systolic pressure of 54 mmHg with a pulmonary capillary wedge pressure of 18 mmHg. She was therefore initiated on vasodilator therapy with sildenafil and macitentan. Extensive workup revealed the likely etiology of her PH to be MM, which at the time was being treated with a proteosome inhibitor. She then underwent a successful autologous peripheral blood stem cell transplant (SCT). After SCT, she noted significant symptomatic improvement in her shortness of breath. Repeat TTE approximately four months post-transplantation showed improved right ventricular function, reduced tricuspid regurgitation, and decreased pulmonary artery systolic pressure. Additionally, her six-minute walk distance improved from 352 meters to 382 meters. Discussion The prevalence of MM with PH remains undefined but is associated with poor prognosis and serves as a management challenge for clinicians due to the lack of treatment guidelines. There are reports of PH being reversible with effective anti-myeloma therapy. In our case, SCT led to a significant reduction of the patient’s PH. One study involving 54 patients with MM-associated PH showed partial response to SCT, though this is not universal. The resolution of MM-related PH after SCT may be due to improvement in hyperviscosity, thrombotic events, anemia with high cardiac output, and VEGF dysregulation. Our case supports the hypothesis of a causal relationship between PH and MM. Treating the underlying MM may help manage PH. This patient’s symptomatic and objective improvement after SCT highlights the importance of recognizing MM-associated PH as a distinct clinical entity. Ongoing monitoring is warranted due to risk of recurrence of PH with relapse of MM.
No takes yet. Share an insight, caveat, or question.
Lew et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: